PFIZER INC - 8-K Filing

Pfizer raises full-year 2026 revenue and adjusted EPS guidance following Q3 results showing 32% operational growth in launched and acquired products. (Items: 2.02 Results of Operations and Financial ConditionOn November 3, 2026, Pfizer Inc, 9.01 Financial Statements and Exhibits(d) ExhibitsExhibit NumberExhibit DescriptionExhibit 99Press Release of Pfizer Inc)

SEC EDGAR · November 3, 2026, 13:07 UTC

Tickers: $PFE

Read the full article at SEC EDGAR

Part of the story ILLINOIS TOOL WORKS INC - 8-K Filing (139 articles)

More Regulatory news

Solana Co - 10-Q Filing SEC EDGAR · November 12, 2026, 13:42 UTC
Solana Co - 8-K Filing SEC EDGAR · November 12, 2026, 13:41 UTC
DeFi Development Corp. - 8-K Filing SEC EDGAR · November 12, 2026, 13:41 UTC
Stablecoin Development Corp - 8-K Filing SEC EDGAR · November 12, 2026, 13:40 UTC
BCP Investment Corp - 8-K Filing SEC EDGAR · November 12, 2026, 13:36 UTC
OneWater Marine Inc. - 8-K Filing SEC EDGAR · November 12, 2026, 13:37 UTC
Moleculin Biotech, Inc. - 8-K Filing SEC EDGAR · November 12, 2026, 13:37 UTC
Investcorp Credit Management BDC, Inc. - 8-K Filing SEC EDGAR · November 12, 2026, 13:37 UTC
Presurance Holdings, Inc. - 10-Q Filing SEC EDGAR · November 12, 2026, 13:35 UTC
Corteva, Inc. - 8-K Filing SEC EDGAR · November 12, 2026, 13:34 UTC